Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2025-12-30 @ 6:28 PM
Study NCT ID:
NCT00080535
Status:
COMPLETED
Last Update Posted:
2018-01-29
First Post:
2004-04-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-04-30
Start Date Type:
ACTUAL
Primary Completion Date:
2011-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2004-04-07
First Submit QC Date:
None
Study First Post Date:
2004-04-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-09-24
Results First Submit QC Date:
None
Results First Post Date:
2012-10-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-02
Last Update Post Date:
2018-01-29
Last Update Post Date Type:
ACTUAL